Sexually Transmitted Infections Flashcards

1
Q

Important Terminology

A

SEXUALLY TRANSMITTED INFECTION (STI) – an infection spread MAINLY via SEXUAL CONTACT
SEXUALLY TRANSMITTED & BLOODBORNE INFECTION (STBBI) – an infection transmitted via the blood OR sexual

The stigma associated with STIs makes our choice of terminology/phrasing IMPORTANT with patients!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Discomfort in Discussing Sexually Transmitted Infections

A

KEY LEARNING POINT

If you are uncomfortable discussing STIs as a healthcare
provider – imagine how the patient feels!
Reluctance to discuss STIs as a provider combined with
reluctance on the part of the patient due to fear of making
you uncomfortable will lead to these problems going
untreated for much longer than necessary

The onus is on US as healthcare providers to identify, address and counsel on these issues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Sexually Transmitted Infections: Epidemiology & Mortality

A
  • Rates of STI have increased dramatically
    over the past decade
  • Between 2008 and 2017:
  • Chlamydia increased by 39%
  • Gonorrhea increased by 109%
  • Syphilis increased by 167%
  • Pan-Canadian Sexually Transmitted and
    Blood-borne Infection Framework for
    Action
  • Comprehensive approach to address STBBI
  • Strategic goals include reducing incidence;
    improving access to testing, treatment and
    ongoing care; reducing stigma and
    discrimination

Hundreds of thousands of patient acquire STIs annually in Canada, only about 50% are aware of it.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sexually Transmitted Infections: Impact of COVID-19

A

Since the start of the COVID-19 pandemic
– the number of STIs reported was 51%
less than expected. This CANNOT be
described solely by reduced rates from
restrictions and social distancing, which
means that STIs are going under-reported
and UNDER-TRACKED.
Re-emergence of STIs in many countries
may be un-monitored in many cases and
this can lead to problems that are going
undetected.

We will see an apparent sharp rise in STIs post-pandemic, but probably it will reflect undetected disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sexually Transmitted Infections: Why are Rates Increasing?

A

Many STIs may be ASYMPTOMATIC for long periods of time (e.g., syphilis, but even gonorrhea or
other STIs in men).
Lack of holistic/comprehensive sexual education, especially RE: condom use!
Disparities and lack of access to healthcare
Why are YMSM at an increased risk for STIs?
* # of partners (variable)
* Frequency of sex without a condom (highlights importance of education RE: condom use!)
* Overlapping sexual networks (when rates of STIs are higher in men, infection rate is higher in MSM)
* Frequency of anal sex

There many be a component of better diagnostic testing/screening that factors into rising rates!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sexually Transmitted Infections: Why Are We Concerned?

A

Beyond the morbidity of the STI itself (causing symptoms,
distress and morbidity on its own) – STIs have a profound
impact on sexual and reproductive health worldwide and
can lead to:
1. Fertility issues (i.e., pelvic inflammatory disease in
women and epididymo-orchitis in men with gonorrhea
and chlamydia)
2. Increased risk of HIV acquisition (with barrier-disrupting
STIs like gonorrheae, syphilis and herpes)
3. Vertical transmission of STIs (causing stillbirth, neonatal
death, low-birth weight, prematurity, sepsis)
4. Increased risks of cancer (e.g., with HPV, cervical cancer
being the 4th most common cancer in women)

STIs can have significant impact on reproductive health and require CAREFUL management.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Sexually Transmitted Infections: A Sexual History – Many WRONG Ways to Approach!

A

The 5 Ps are useful for taking a sexual history: but there are many WRONG ways to approach a sexual history.
1. Partners (#)
* How many partners have you had?
* Who are the clients’ partners? (men, women or both?) – NOT requiring orientation
2. Practices
* What types of sex does the patient engage in? (vaginal, anal, oral; not assuming any based-on clients’
partners or orientation)
3. Protection
* Does the patient use barrier methods? How frequently?
4. Past History of STIs
5. Prevention of Pregnancy?
* Using birth control or consistent condom use?

Discussing sexual health & sexual behavior is a sensitive topic! Confirm confidentiality!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Sexually Transmitted Infections: An Overview

see slide12

A

SEXUALLY TRANSMITTED
INFECTIONS

URETHRITIS / CERVICITIS (urethral discharge, pain with sex, dysuria)
Gonorrhea
Chlamydia
Trichomoniasis
Mycoplasma &
Ureaplasma

GENITAL WARTS & Ectoparasites
HPV Public lice

PAINLESS ULCERS
Syphilis
Granuloma
inguinale

PAINFUL ULCERS
Genital Herpes
Chancroid
LGV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Antimicrobials Are For PATHOGENS

A

Kill the PATHOGEN
that is CAUSING
the disease! This
means we always
need to be
thinking: “what
pathogens are at
play in my specific
patient”?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A Case of Urethritis
Recognition of the right pathogen is important to select the right treatment!
https://www.alberta.ca/notifiable-disease-guidelines.aspx#jumplinks-4
A 23-year-old woman presents to the sexually
transmitted infection (STI) clinic with vaginal discharge,
left ocular discharge, and blurry vision. A urine sample of
the vaginal discharge and ocular discharge both show
abundant white blood cells and numerous gramnegative intracellular diplococci.
Q: What is the most likely pathogen at play?

A

Recognition of the right pathogen is important to select the right treatment!

Neisseria gonorrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Gonorrhea: Epidemiology & Morbidity

A
  • Second most frequently reported notifiable STI in
    Alberta and Canada
  • Gonorrhea outbreak declared in Alberta in 2016 due to
    rising cases
  • Global and national concern about the continuing
    emergence of drug resistant strains of gonorrhea
  • Noticed more frequently in males (more likely
    symptomatic), increasing rates in MSM)
  • Risk factors: multiple/new partners, unprotected sex,
    alcohol/substance use, sex workers & street-involved
    youth

Around 25-30% of patients with gonorrhea are COINFECTED with Chlamydia!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Gonorrhea: The Causative Pathogen & Transmission

A

PATHOGEN: Neisseria gonorrhoeae (gram-negative
diplococcus)
TRANSMISSION:
* Contact via sexual activity (fluids/direct contact, oral,
vaginal or anal sex)
* Possible increased rate of MALE > FEMALE (but any if
receptive sex, anal/vaginal?)
* Transmission possible PERINATAL
* Incubation Period: 2-7 days
Increases rates of HIV acquisition!
* Urethritis increases VIRAL SHEDDING of HIV (i.e.,
contact with blood/mucous membranes via sexual
activity)

MEN are typically more SYMPTOMATIC than females!! (detected via exam/testing more frequently in females)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Urethritis: Gonococcal vs. Non-Gonococcal

A

GONOCOCCAL
URETHRITIS
(aka. Gonorrhea)

NON-GONOCOCCAL
URETHRITIS (NGU)
Referring mostly to Chlamydia, but also
technically to the much less common
Mycoplasma/Ureaplasma urethritis
Urethritis: inflammation of the urethra, causing discharge, dysuria, and possibly itchiness or irritation.

Patients may refer to this as the drip or “the clap” (reference to “the clapier” referring to brothels)

Gonorrhea: Oropharyngeal & Conjunctival Gonorrhea
Hyperacute gonococcal conjunctivitis can lead to CORNEAL ULCERATION AND BLINDNESS!
v

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Gonorrhea: Neonatal Gonorrheal Conjunctivitis

A

Neonatal gonorrheal infection predominantly occurs
from perinatal exposure to the mother’s infected cervix
during birth. This can therefore be prevented with
routine prenatal screening!
The most common manifestations include:
* Ophthalmia neonatorum (gonococcal
keratoconjunctivitis) – CAUSES BLINDNESS
* Neonatal sepsis/meningitis
Despite negative screening we still GIVE ALL
NEWBORNS erythromycin 0.5% ung OU x 1

Routine erythromycin ointment application at birth is STILL given to reduce preventable blindness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Gonorrhea: Disseminated Gonococcal Infection (DGI)

A

Disseminated gonococcal infection (DGI) can
occur through hematogenous spread of Neisseria
but only occurs in <1% of all cases, predominantly
in women.
Organ systems that can be involved include:
* Skin (cutaneous findings)
* Tendon sheaths/joints (tenosynovitis)
* Pericardium (pericarditis)
* Endocardium (infective endocarditis; RARE)
* Meningitis
* Bacterial hepatitis

Samples of arthritis can be STERILE – so careful attention to history of primary gonorrhea is important!

Migratory polyarthralgia

. Specifically, it seems to be mostly their hands, and they can be bilateral.
Then, when you do a joint t of these of these patients, typically they’ll be culture negative, but they’ll have swab positive, or urine culture positive gonorrhea,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Gonorrhea: Clinical Presentation & Complications

A

GENITOURINARY:
* Cervicitis (abnormal vaginal
discharge, bleeding between periods,
lower abdominal pain)
* Urethritis (dysuria,
purulent/mucopurulent urethral
discharge)
* FEMALES: pelvic inflammatory
disease (PID)
* MALES: epididymo-orchitis
RECTAL:
* Proctitis (rectal pain, bleeding)

HEENT:
* Hyperacute gonococcal conjunctivitis
* Gonococcal pharyngitis
DISSEMINATED DISEASE:
* Disseminated gonococcemia
PREGNANCY:
* Increased obstetrical/maternal complications
* Increased infant prenatal fatality
* Increased risk of prematurity, lower birthb weight

Infection is often ASYMPTOMATIC in females (~50%); more so symptomatic in males!

17
Q

Pelvic Inflammatory Disease (PID)

A

Pelvic inflammatory disease (PID) refers to the infection
of the uterus, fallopian tubes and/or ovaries typically as a
result of ascending spread or vaginal/cervical infection in
females.
PATHOGENS: therefore, most frequently gonorrhea,
chlamydia, but also other vaginal anaerobes or
commensals (i.e., Streptococci)
COMPLICATIONS: tubo-ovarian abscess, damage to
uterine wall reduced fertility capacity
TREATMENT: often hospital admit, antibiotics targeting
the above pathogens for ~7-14/7

Fertility issues related to G/C are most commonly due to complication by PID.

And so we think this is by ascending route of spread, so actually starting in the cervix, and actually ascending.
complication that leads to infertility in females in particular, is this tuba ovarian abscess. This is an ultrasound of one in particular, and we’ve seen quite a few of these. Actually, unfortunately, where there’s an abscess that grows on the Philopian tube, and for treatment it actually requires total removal of that Fallopia tube, and so treatment is generally aggressive,
It has to be emphasized to patients that there certainly can be fertility risks associated with these, and it has to do with patients delaying treatment and eventually developing these complications like Pid

  • Don’t memorize the 7 to 14 days of treatment. I would memorize, for example, that this can be a polymcrobial anaerobic gonorrhea chlam problem as well
18
Q

Gonorrhea: Diagnosis & Recognition

A

Diagnosis often highly suspicious via history and
physical alone (often able to express discharge in males
in acute disease) but confirmed depending on the SITE
INFECTED:
URETHRITIS / CERVICITIS:
* Urine NAT Testing for G/C (also detects Chlamydia
trachomatis if present) – detects DEAD organism as
well!
* NAT can also be done with cervical/urethral swabs
EYE/PHARYNX/RECTAL INVOLVEMENT:
* Gram-stain, culture & sensitivity (like most bacterial
illness)

Diagnosis of gonorrhea/chlamydia is SIMPLE and only requires a URINE SAMPLE!

19
Q

Gonorrhea: Historical Treatment & Drug-Resistance

A

you can be sure that we were blasting gonorrhea with penicillin right from the very beginning, including with T and Psmx, which no longer is effective and tetr cyclins, which are no longer affected. And so you can see with this timeline we used to use a lot of agents that we simply don’t use anymore, and the rise of resistance is pretty precipitous for some agents in particular.

Ciprflox no longer used
Cefixime not recommended - doesnt apply in AB

we don’t have any drug resistant gonorrhea episodes here but we’re expecting that in the next few years I watch you see one.

20
Q

Gonorrhea: Historical Treatment & Drug-Resistance
Memorizing Antibiotic Spectra: Advanced & Adjunct Agents for Gram-Positive Pathogens
Memorizing Antibiotic Spectra: Agents for BL-Resistant Gram-Negative Infections
Memorizing Antibiotic Spectra: Atypicals & Anaerobes

A

VLD is useful for drug-resistant G+ organisms (MRSA/VRE). Clindamycin is rarely clinically useful and justified.
Tetracyclines can be useful elsewhere, but notice macrolides = ~atypicals only, metronidazole = anaerobes only.

21
Q

Gonorrhea: Current Alberta Treatment Guidelines

Uncomplicated urethral and cervical infection
* Heterosexual / Pregnant Individual

A
  • Preferred:
  • Cefixime 800 mg po as a single dose PLUS azithromycin 1 g po as a single dose
  • Alternate:
  • Ceftriaxone 250mg IM as a single dose PLUS azithromycin* 1 g po as a single dose
    OR (not recommended in pregnancy)
  • Azithromycin 2 g po as a single dose PLUS gentamicin 240 mg IM in 2 separate 3-mL injections of
    40mg/mL solution
    OR (not recommended in pregnancy)
  • Azithromycin 2 g po as a single dose PLUS gemifloxacin** 320mg PO in a single dose

*Azithromycin resistance has been reported, this agent should not be used as a monotherapy
Abstinence from unprotected sex for ~7-days is generally recommended; mostly to protect others.

22
Q

Gonorrhea: Current Alberta Treatment Guidelines
* MSM (any site) and Pharyngeal Infections

A

Preferred:
* Ceftriaxone 250 mg IM as a single dose PLUS azithromycin 1 g po as a single dose
Alternate:
* Cefixime 800 mg po as a single dose PLUS azithromycin 1 g po as a single dose
OR (not recommended in pregnancy)
* Azithromycin 2 g PO as a single dose PLUS gentamicin 240 mg IM in 2 separate 3-mL
injections of 40mg/mL solution
OR (not recommended in pregnancy)
* Azithromycin 2 g PO as a single dose PLUS gemifloxacin 320mg PO in a single dose

The risk of drug-resistant gonorrhea may be higher in the MSM population.

23
Q

Gonorrhea: Test Of Cure?

A
  • Test of cure (TOC) is recommended for all cases of GC
  • TOC using NAAT, should be performed 3-4 weeks after the completion of
    treatment (why wait so long?)
  • Re-screening of all individuals diagnosed with GC is recommended after 6 months
    Test of cure is important to detect drug-resistant gonorrhea early.
24
Q

A Case of Urethritis
Recognition of the right pathogen is important to select the right treatment!
https://www.alberta.ca/notifiable-disease-guidelines.aspx#jumplinks-4
A 17-year-old male presents to the sexually transmitted
infection (STI) clinic with burning with urination, urethral
discharge and discomfort. Urine microscopy is taken
which reveals no visible organisms (i.e., nil gramnegative diplococci visible).
Q: What is the most likely pathogen at play?
Q: What TYPE of bacteria is this pathogen? Grampositive? Gram-negative?

A

ok